SECOND MALIGNANCIES IN 559 PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB FRONTLINE: DATA FROM THE GIMEMA CML WORKING PARTY

被引:0
|
作者
Gugliotta, G. [1 ]
Castagnetti, F. [1 ]
Palandri, F. [1 ]
Breccia, M. [2 ]
Radaelli, F. [3 ]
Capucci, A. [4 ]
Cavazzini, F. [5 ]
Ferrero, D. [6 ]
Stagno, F. [7 ]
Gherlinzoni, F. [4 ]
Di Lorenzo, R. [4 ]
Leoni, P. [8 ]
Cambrin, G. Rege [6 ]
Ferrara, F. [4 ]
Alimena, G. [2 ]
Martinelli, G. [1 ]
Pane, F. [9 ]
Saglio, G. [6 ]
Baccarani, M. [1 ]
Rosti, G. [1 ]
机构
[1] Univ Bologna, S Orsola M Malpighi Hosp, Inst L & Seragnoli, Bologna, Italy
[2] Univ Roma La Sapienza, Dept Haematol, Rome, Italy
[3] Univ Milan, Dept Haematol, Milan, Italy
[4] Haematol Unit, Brescia, Italy
[5] Univ Ferrara, Dept Haematol, I-44100 Ferrara, Italy
[6] Univ Turin, Dept Haematol, Turin, Italy
[7] Univ Catania, Dept Haematol, Catania, Italy
[8] Univ Ancona, Dept Haematol, Ancona, Italy
[9] Univ Naples Federico II, Dept Haematol, Naples, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0805
引用
收藏
页码:337 / 337
页数:1
相关论文
共 50 条
  • [1] Incidence and Mortality of Second Malignancies In 559 Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib Frontline: Data From the GIMEMA CML Working Party.
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Palandri, Francesca
    Breccia, Massimo
    Cavazzini, Francesco
    Di Lorenzo, Roberto
    Levato, Luciano
    Girasoli, Mariella
    Leone, Giuseppe
    Abruzzese, Elisabetta
    Tiribelli, Mario
    Meneghini, Vittorio
    Galieni, Piero
    Trabacchi, Elena
    Alimena, Giuliana
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2010, 116 (21) : 939 - 940
  • [2] Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Palandri, Francesca
    Breccia, Massimo
    Intermesoli, Tamara
    Capucci, Adele
    Martino, Bruno
    Pregno, Patrizia
    Rupoli, Serena
    Ferrero, Dario
    Gherlinzoni, Filippo
    Montefusco, Enrico
    Bocchia, Monica
    Tiribelli, Mario
    Pierri, Ivana
    Grifoni, Federica
    Marzocchi, Giulia
    Amabile, Marilina
    Testoni, Nicoletta
    Martinelli, Giovanni
    Alimena, Giuliana
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2011, 117 (21) : 5591 - 5599
  • [3] Frontline Treatment With Imatinib Mesylate in Chronic Myeloid Leukemia Patients in Early Chronic Phase: a Very Long-Term Analysis by the GIMEMA CML Working Party
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Breccia, Massimo
    Specchia, Giorgina
    Intermesoli, Tamara
    Capucci, Adele
    Martino, Bruno
    Tiribelli, Mario
    Binotto, Gianni
    Abruzzese, Elisabetta
    Stagno, Fabio
    Leoni, Pietro
    Ferrero, Dario
    Gherlinzoni, Filippo
    Palandri, Francesca
    Venturi, Claudia
    Bochicchio, Maria Teresa
    Soverini, Simona
    Alimena, Giuliana
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuseppe
    Cavo, Michele
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2013, 122 (21)
  • [4] PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Specchia, G.
    Binotto, G.
    Abruzzese, E.
    Iurlo, A.
    Vigneri, P.
    Cavazzini, F.
    Intermesoli, T.
    Ferrero, D.
    Martino, B.
    Leoni, P.
    Bocchia, M.
    Rege-Cambrin, G.
    Gherlinzoni, F.
    Bochicchio, M. T.
    Soverini, S.
    Alimena, G.
    Pane, F.
    Saglio, G.
    Cavo, M.
    Martinelli, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2015, 100 : 324 - 324
  • [5] FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS
    Gugliotta, G.
    Castagnetti, F.
    Breccia, M.
    Levato, L.
    Fava, C.
    Luciano, L.
    Zaccaria, A.
    Rossi, A. Russo
    Usala, E.
    Gozzini, A.
    Vigneri, P.
    Cedrone, M.
    Tiribelli, M.
    Abruzzese, E.
    Avanzini, P.
    Palandri, F.
    Soverini, S.
    Alimena, G.
    Pane, F.
    Martinelli, G.
    Cavo, M.
    Saglio, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2014, 99 : 333 - 333
  • [6] INCIDENCE OF ABL KINASE DOMAIN MUTATIONS IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH FAILURE OR SUBOPTIMAL RESPONSE TO FRONTLINE IMATINIB TREATMENT - AN ANALYSIS BY THE GIMEMA WORKING PARTY ON CML
    Soverini, S.
    Colarossi, S.
    Gnani, A.
    Castagnetti, F.
    Abruzzese, E.
    Orlandi, E.
    Tiribelli, M.
    Breccia, M.
    Specchia, G.
    Palandri, F.
    Poerio, A.
    Amabile, M.
    Iacobucci, I.
    Ciccarese, F.
    Rosti, G.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA, 2008, 93 : S71 - S71
  • [7] SOKAL SCORE AND RESPONSE TO IMATINIB IN EARLY CHRONIC PHASE CML: THE GIMEMA CIVIL WORKING PARTY EXPERIENCE ON 559 PATIENTS
    Baccarani, M.
    Rosti, G.
    Castagnetti, F.
    Palandri, F.
    Gugliotta, G.
    Ferrara, F.
    Gozzini, A.
    Pulini, S.
    Montefusco, E.
    Sica, S.
    Turri, D.
    Ferrero, D.
    Musolino, C. M.
    Bocchia, M. B.
    Radaelli, F. R.
    Martinelli, G. M.
    Breccia, M. B.
    Pane, F. P.
    Saglio, G. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 254 - 254
  • [8] Outcome of 472 Chronic Myeloid Leukemia Patients Treated with Frontline Nilotinib: A Gimema CML WP Analysis
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Breccia, Massimo
    Iurlo, Alessandra
    D'Adda, Mariella
    Stagno, Fabio
    Levato, Luciano
    Martino, Bruno
    Lunghi, Francesca
    Tiribelli, Mario
    Cambrin, Giovanna Rege
    Abruzzese, Elisabetta
    Rupoli, Serena
    Gozzini, Antonella
    Pregno, Patrizia
    Salvucci, Marzia
    Trabacchi, Elena
    Caocci, Giovanni
    Scortechini, Anna Rita
    Luciano, Luigia
    Tagariello, Giuseppe
    Bonifacio, Massimiliano
    Soverini, Simona
    Foa, Robin
    Martinelli, Giovanni
    Cavo, Michele
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2018, 132
  • [9] Old Age Affects Survival but Not Response in Philadelphia Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients Treated with Imatinib (IM): A Study of the GIMEMA CML WORKING PARTY.
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Palandri, Francesca
    Breccia, Massimo
    Amabile, Marilina
    Soverini, Simona
    Testoni, Nicoletta
    Marzocchi, Giulia
    Baldazzi, Carmen
    Annunziata, Mario
    Usala, Emilio
    Sica, Simona
    Tiribelli, Mario
    Bocchia, Monica
    Gozzini, Antonella
    Russo, Sabina
    Palmieri, Fausto
    Meneghini, Vittorio
    D'Emilio, Anna
    Alimena, Giuliana
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2009, 114 (22) : 458 - 459
  • [10] LONG TERM OUTCOME OF 559 PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONT-LINE WITH IMATINIB: 5-YEAR RESULTS OF 3 INDEPENDENT STUDIES OF THE GIMEMA CML WORKING PARTY
    Castagnetti, F.
    Palandri, F.
    Gugliotta, G.
    Breccia, M.
    Specchia, G.
    Abruzzese, E.
    Levato, L.
    Intermesoli, T.
    Martino, B.
    Pregno, P.
    Orlandi, E.
    Iacobucci, I.
    Soverini, S.
    Testoni, N.
    Alimena, G.
    Martinelli, G.
    Pane, F.
    Saglio, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 54 - 54